Insider filing · STOK
Adrian R. Krainer
Director
profile →
Stoke Therapeutics, Inc.
STOK · Healthcare · 35 filings in 24 months
ticker →
Adrian R. Krainer sold $1.1M of Stoke Therapeutics (STOK)
Executed Nov 14 2025, disclosed Nov 18 2025, 4 days later.
Value, as filed
$1.1M
40,472 sh across 2 lots
Executed
Nov 14 2025
the trade date, as filed
Disclosed
Nov 18 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AKAdrian R. Krainer (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $1.3M of STOK (33,243 sh × $39.74, as filed), executed Mar 10.
The name
STOKHealthcare · Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Adrian R. Krainer in STOK
STOKSALE
Stoke Therapeutics, Inc.
$1.3M33,243 sh × $39.74
Exec Mar 10
Filed Mar 12 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $287K
7,229 sh × $39.66
Exec Mar 2
Filed Mar 4 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $1.2M
40,472 sh × $29.72
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET